Speciality healthcare solutions company.
Issues relating to incentives for life sciences research.
H.R. 160: Protect Medical Innovation Act of 2015.
Tax treatment of inverted companies.
Tax issues in mergers and acquisitions of US firms. Oversight of implementation of the America Invents Act.
Issues relating to patent settlements.
H.R. 9: The Innovation Act.
S. 1137: Protecting American Talent and Entrepreneurship Act of 2015 (PATENT Act).
Issues relating to misuse of the inter pares review process. Issues relating to prescription drug abuse.
Issues relating to incentives for tamper-resistant formulations.
Issues relating to FDA approvals of new drugs and generic drugs.
Issues related to the FDA.
Issues related to Opioids.
Issues relating to Medicare Part D rebates.
Compounding and drug supply chain legislation.
House 21st Century Cures bill (Senate companion which includes NIH and FDA issues).
H.R. 471/S. 483: Ensuring Patient Access and Effective Drug Enforcement Act of 2015.
Issues relating to the labeling of generic drugs.
Issues relating to CDC guidance for prescribing opioids.
S. 2948 and H.R. 5748 - The Medicaid Generic Drug Price Fairness Act.
Issues relating to products containing high doses of acetaminophen.
Issues relating to the labeling of generic drugs.
Issues relating to removal of FDA unapproved products from the market.
TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 2 - HOUSE OF REPRESENTATIVES 2 - HOUSE OF REPRESENTATIVES
THE GIBSON GROUP, LLC
601 Thirteenth Street, N.W., Suite B2 North, Washington, DC, 20005, US
JOSEPH H GIBSON JOSEPH H GIBSON JOSEPH H GIBSON (Counsel for Legislative & Intergovernmental Affairs Anti-Trust Division, DOJ 2001-2002; Chief Antitrust Counsel, House Judiciary Committee 1997-2001; Counsel, House Judiciary Committee 1995-1997)
Counsel for Legislative & Intergovernmental Affairs Anti-Trust Division, DOJ 2001-2002; Chief Antitrust Counsel, House Judiciary Committee 1997-2001; Counsel, House Judiciary Committee 1995-1997